Literature DB >> 19589435

Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.

Christopher J McLeod1, Michael J Ackerman, Rick A Nishimura, A Jamil Tajik, Bernard J Gersh, Steve R Ommen.   

Abstract

OBJECTIVES: This study sought to clarify the frequency, clinical phenotype, and prognosis of those patients with hypertrophic cardiomyopathy (HCM) who present with a normal electrocardiogram (ECG).
BACKGROUND: Hypertrophic cardiomyopathy is the most common cause of sudden death in young people. Screening advocates have recommended a 12-lead ECG for the early detection of HCM in athletes, yet the clinical outcomes of those presenting with a normal ECG remains to be fully delineated.
METHODS: Baseline characteristic and echocardiographic data were collected on all patients with HCM who initially presented to our institution with a diagnostic echocardiogram but a normal ECG. Follow-up was obtained and compared with the prognosis of HCM patients who presented with abnormal ECGs.
RESULTS: We compared 135 HCM patients with a normal ECG with 2,350 HCM patients with an abnormal ECG. The latter group was more likely to have worse symptoms, have higher gradients, and a greater degree of septal wall thickness than the patients with a normal ECG. Severe obstructive symptoms requiring surgical myectomy and implantation of an implantable cardioverter-defibrillator were more common in patients with abnormal ECGs. Cardiac survival was significantly better in the group with a normal ECG at presentation-none of these patients had a cardiac death at follow-up.
CONCLUSIONS: Almost 6% of patients presenting with demonstrable echocardiographic evidence of HCM had a normal ECG at the time of diagnosis. This subset of patients with normal ECG-HCM appears to exhibit a less severe phenotype with better cardiovascular outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19589435     DOI: 10.1016/j.jacc.2009.02.071

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

Review 1.  Chromosomal regulation by MeCP2: structural and enzymatic considerations.

Authors:  N J Bowen; M B Palmer; P A Wade
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

Review 2.  The year of 2009 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

3.  [The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].

Authors:  B Maisch; H Mahrholdt
Journal:  Herz       Date:  2014-12       Impact factor: 1.443

4.  Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.

Authors:  Neal K Lakdawala; Jens Jakob Thune; Barry J Maron; Allison L Cirino; Ole Havndrup; Henning Bundgaard; Michael Christiansen; Christian M Carlsen; Jean-François Dorval; Raymond Y Kwong; Steven D Colan; Lars V Køber; Carolyn Y Ho
Journal:  Am J Cardiol       Date:  2011-09-21       Impact factor: 2.778

5.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

Review 6.  The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.

Authors:  Iacopo Olivotto; Francesca Girolami; Stefano Nistri; Alessandra Rossi; Luigi Rega; Francesca Garbini; Camilla Grifoni; Franco Cecchi; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2009-10-27       Impact factor: 4.132

Review 7.  Sudden death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron
Journal:  J Cardiovasc Transl Res       Date:  2009-11-13       Impact factor: 4.132

Review 8.  The diagnosis and treatment of hypertrophic cardiomyopathy.

Authors:  Christian Prinz; Martin Farr; Detlef Hering; Dieter Horstkotte; Lothar Faber
Journal:  Dtsch Arztebl Int       Date:  2011-04-01       Impact factor: 5.594

9.  Electromechanical relationship in hypertrophic cardiomyopathy.

Authors:  Xiaoping Lin; Hsin-Yueh Liang; Aurelio Pinheiro; Veronica Dimaano; Lars Sorensen; Miguel Aon; Larisa G Tereshchenko; Yihan Chen; Meixiang Xiang; Theodore P Abraham; M Roselle Abraham
Journal:  J Cardiovasc Transl Res       Date:  2013-06-15       Impact factor: 4.132

Review 10.  Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies.

Authors:  Hamayak Sisakian
Journal:  World J Cardiol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.